Company · CIK 0000784199 · SIC 3841 — Surgical & Medical Instruments & Apparatus · NYSE
ARTIVION, INC. · AORT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2018 SForm 4 → | May 8, 4:24 pm EDT | John E DavisSenior VP, Global Sales | 3,334 | $24.00 | $80,016 | 51,438 | −6.09% | plan? late |
| May 3, 2018 MForm 4 → | May 8, 4:24 pm EDT | John E DavisSenior VP, Global Sales | 3,334 | $9.64 | $32,140 | 54,772 | — | plan? late |
| Apr 17, 2018 SForm 4 → | Apr 18, 4:42 pm EDT | John E DavisSenior VP, Global Sales | 3,333 | $23.00 | $76,659 | 51,438 | −6.09% | plan? |
| Apr 17, 2018 MForm 4 → | Apr 18, 4:42 pm EDT | John E DavisSenior VP, Global Sales | 3,333 | $9.64 | $32,130 | 54,771 | — | plan? |
| Apr 1, 2018 FForm 4 → | Apr 3, 8:58 am EDT | Jean F HollowayVP, General Counsel | 2,125 | $20.05 | $42,606 | 57,877 | — | plan? |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:52 pm EDT | James M McDermidSVP, CHRO | 6,187 | — | — | 21,339 | — | plan? |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:51 pm EDT | James P MackinPresident & CEO | 30,162 | — | — | 351,095 | — | plan? |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:50 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 8,507 | — | — | 300,079 | — | plan? |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:50 pm EDT | Amy HortonVP, Chief Accounting Officer | 4,834 | — | — | 102,959 | — | plan? |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:49 pm EDT | Jean F HollowayVP, General Counsel | 7,425 | — | — | 60,002 | — | plan? |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:48 pm EDT | John E DavisSenior VP, Global Sales | 6,187 | — | — | 51,438 | — | plan? |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:47 pm EDT | Scott B CappsVP, Clinical Research | 3,867 | — | — | 139,087 | — | plan? |
| Mar 8, 2018 SForm 4 → | Mar 9, 4:51 pm EST | Ronald D McCallDirector | 5,000 | $21.09 | $105,448 | 146,511 | −3.30% | plan? |
| Mar 8, 2018 SForm 4 → | Mar 9, 4:51 pm EST | C Elkins RonaldDirector | 2,000 | $22.00 | $44,000 | 97,849 | −2.00% | plan? |
| Mar 5, 2018 AFForm 4 → | Mar 26, 4:31 pm EDT | William Robert MatthewsSenior VP, Operations, Quality | 6,538 | $19.15 | $16,967 | 39,883 | — | plan? late |
| Mar 5, 2018 AFForm 4 → | Mar 7, 5:26 pm EST | James P MackinPresident & CEO | 34,349 | $19.15 | $121,583 | 320,933 | — | plan? |
| Mar 5, 2018 AFForm 4 → | Mar 7, 5:26 pm EST | James M McDermidSVP, CHRO | 6,649 | $19.15 | $19,093 | 15,152 | — | plan? |
| Mar 5, 2018 AFForm 4 → | Mar 7, 5:26 pm EST | David Ashley LeeExecutive VP, COO & CFO | 9,445 | $19.15 | $23,842 | 291,572 | — | plan? |
| Mar 5, 2018 AFForm 4 → | Mar 7, 5:26 pm EST | Amy HortonVP, Chief Accounting Officer | 5,298 | $19.15 | $13,367 | 98,125 | — | plan? |
| Mar 5, 2018 AFForm 4 → | Mar 7, 5:19 pm EST | Jean F HollowayVP, General Counsel | 7,804 | $19.15 | $19,571 | 52,577 | — | plan? |
| Mar 5, 2018 AFForm 4 → | Mar 7, 5:19 pm EST | John E DavisSenior VP, Global Sales | 7,457 | $19.15 | $18,327 | 45,251 | — | plan? |
| Mar 5, 2018 AFForm 4 → | Mar 7, 5:19 pm EST | Scott B CappsVP, Clinical Research | 4,607 | $19.15 | $11,624 | 135,220 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 7:50 pm EST | David Ashley LeeExecutive VP, COO & CFO | 3,744 | $18.25 | $68,328 | 284,617 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 7:46 pm EST | Amy HortonVP, Chief Accounting Officer | 1,480 | $18.25 | $27,010 | 94,223 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 7:44 pm EST | Scott B CappsVP, Clinical Research | 2,246 | $18.25 | $40,990 | 131,827 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 7:44 pm EST | James P MackinPresident & CEO | 9,527 | $18.25 | $173,868 | 299,282 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 5:26 pm EST | William Robert MatthewsSenior VP, Operations, Quality | 1,183 | $18.25 | $21,590 | 35,117 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 5:23 pm EST | James P MackinPresident & CEO | 7,640 | $18.25 | $139,430 | 308,809 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 5:23 pm EST | David Ashley LeeExecutive VP, COO & CFO | 2,788 | $18.25 | $50,881 | 288,361 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 5:20 pm EST | Amy HortonVP, Chief Accounting Officer | 1,502 | $18.25 | $27,412 | 95,703 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 5:18 pm EST | Jean F HollowayVP, General Counsel | 1,877 | $18.25 | $34,255 | 46,817 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 5:16 pm EST | John E DavisSenior VP, Global Sales | 1,183 | $18.25 | $21,590 | 39,708 | — | plan? |
| Feb 19, 2018 FForm 4 → | Feb 21, 5:15 pm EST | Scott B CappsVP, Clinical Research | 1,521 | $18.25 | $27,758 | 134,073 | — | plan? |
| Feb 13, 2018 FMForm 4 → | Feb 15, 5:28 pm EST | Scott B CappsVP, Clinical Research | 40,714 | $7.88 | $320,840 | 135,594 | — | plan? |
| Jan 1, 2018 MForm 4 → | Jul 10, 4:49 pm EDT | Sherry M SauriniVP, Quality | 191 | $16.24 | $3,101 | 26,274 | — | plan? late |
| Jan 1, 2018 MForm 4 → | Jul 10, 4:47 pm EDT | James M McDermidSVP, CHRO | 1,179 | $16.24 | $19,141 | 22,518 | — | plan? late |
| Jan 1, 2018 MForm 4 → | Jul 10, 4:46 pm EDT | Jean F HollowayVP, General Counsel | 861 | $16.24 | $13,978 | 58,738 | — | plan? late |
| Jan 1, 2018 MForm 4 → | Jul 10, 4:43 pm EDT | John E DavisSenior VP, Global Sales | 4,699 | $16.28 | $76,509 | 56,137 | — | plan? late |
| Dec 31, 2017 MForm 5 → | Jan 25, 2018, 4:47 pm EST | James M McDermidSVP, CHRO | 821 | $16.28 | $13,364 | 10,497 | — | plan? |
| Dec 31, 2017 MForm 5 → | Jan 25, 2018, 4:46 pm EST | Jean F HollowayVP, General Counsel | 567 | $16.28 | $9,229 | 48,694 | — | plan? |
| Dec 15, 2017 SForm 4 → | Dec 19, 5:30 pm EST | C Elkins RonaldDirector | 1,000 | $20.00 | $20,000 | 99,849 | −0.99% | plan? |
| Nov 16, 2017 SForm 4 → | Nov 17, 4:17 pm EST | David C GaleVP, Research & Development | 20,000 | $19.63 | $392,500 | 77,135 | −20.6% | plan? |
| Nov 16, 2017 MForm 4 → | Nov 17, 4:17 pm EST | David C GaleVP, Research & Development | 20,000 | $5.94 | $118,800 | 87,135 | — | plan? |
| Nov 8, 2017 SForm 4 → | Nov 13, 4:47 pm EST | David Ashley LeeExecutive VP, COO & CFO | 63,333 | $18.80 | $1,190,438 | 291,149 | −17.9% | plan? late |
| Nov 8, 2017 MForm 4 → | Nov 13, 4:47 pm EST | David Ashley LeeExecutive VP, COO & CFO | 63,333 | $5.12 | $324,265 | 321,292 | — | plan? late |
| Nov 8, 2017 GForm 4 → | Nov 13, 4:45 pm EST | Amy HortonVP, Chief Accounting Officer | 1,500 | — | — | 97,205 | — | plan? late |
| Nov 8, 2017 SForm 4 → | Nov 13, 4:45 pm EST | Amy HortonVP, Chief Accounting Officer | 4,000 | $19.00 | $76,000 | 98,705 | −3.89% | plan? late |
| Nov 6, 2017 SForm 4 → | Nov 8, 5:22 pm EST | C Elkins RonaldDirector | 1,000 | $19.03 | $19,030 | 100,849 | −0.98% | plan? |
| Oct 2, 2017 SForm 4 → | Oct 4, 4:49 pm EDT | James BensonDirector | 2,000 | $22.80 | $45,600 | 54,086 | −3.57% | plan? |
| Sep 5, 2017 SForm 4 → | Sep 6, 5:43 pm EDT | James P MackinPresident & CEO | 125,000 | $22.01 | $2,751,740 | 316,449 | −28.3% | plan? |
| Sep 5, 2017 SForm 4 → | Sep 6, 5:42 pm EDT | C Elkins RonaldDirector | 1,000 | $22.00 | $22,000 | 101,849 | −0.97% | plan? |
| Jul 5, 2017 GForm 4 → | Jul 6, 5:02 pm EDT | Harvey MorganDirector | 8,734 | — | — | 40,667 | — | plan? |
| Jul 3, 2017 DForm 4 → | Jul 6, 5:03 pm EDT | James BensonDirector | 2,000 | $19.95 | $39,900 | 56,086 | — | plan? |
| Jun 27, 2017 SForm 4 → | Jun 29, 9:19 am EDT | Amy HortonVP, Chief Accounting Officer | 9,577 | $20.00 | $191,540 | 102,705 | −8.53% | plan? |
| Jun 27, 2017 MForm 4 → | Jun 29, 9:19 am EDT | Amy HortonVP, Chief Accounting Officer | 18,667 | $5.12 | $95,575 | 112,282 | — | plan? |
| May 22, 2017 DForm 4 → | May 24, 9:21 am EDT | Ronald D McCallDirector | 7,000 | $18.28 | $127,938 | 151,511 | — | plan? |
| May 17, 2017 AForm 4 → | May 18, 4:45 pm EDT | Harvey MorganDirector | 5,263 | — | — | 50,299 | — | plan? |
| May 17, 2017 AForm 4 → | May 18, 4:43 pm EDT | Jon W SalvesonDirector | 5,263 | — | — | 79,349 | — | plan? |
| May 17, 2017 AForm 4 → | May 18, 4:39 pm EDT | Ronald D McCallDirector | 5,263 | — | — | 158,511 | — | plan? |
| May 17, 2017 AForm 4 → | May 18, 4:35 pm EDT | C Elkins RonaldDirector | 5,263 | — | — | 102,849 | — | plan? |
| May 17, 2017 AForm 4 → | May 18, 4:33 pm EDT | James BullockDirector | 5,263 | — | — | 8,266 | — | plan? |
| May 17, 2017 AForm 4 → | May 18, 4:24 pm EDT | Daniel J BevevinoDirector | 5,263 | — | — | 99,349 | — | plan? |
| May 17, 2017 AForm 4 → | May 18, 4:23 pm EDT | Thomas F AckermanDirector | 5,263 | — | — | 99,349 | — | plan? |
| Apr 3, 2017 DForm 4 → | Apr 10, 4:57 pm EDT | James BensonDirector | 2,000 | $16.60 | $33,200 | 58,086 | — | plan? late |
| Feb 26, 2017 AFForm 4 → | Feb 28, 5:33 pm EST | Amy HortonVP, Chief Accounting Officer | 2,502 | $17.25 | $43,160 | 93,615 | — | plan? |
| Feb 26, 2017 FForm 4 → | Feb 28, 5:31 pm EST | David C GaleVP, Research & Development | 3,752 | $17.25 | $64,722 | 77,135 | — | plan? |
| Feb 26, 2017 FForm 4 → | Feb 28, 5:28 pm EST | Scott B CappsVP, Clinical Research | 3,752 | $17.25 | $64,722 | 113,642 | — | plan? |
| Feb 26, 2017 FForm 4 → | Feb 28, 5:27 pm EST | David Ashley LeeExecutive VP, COO & CFO | 6,254 | $17.25 | $107,882 | 291,149 | — | plan? |
| Feb 22, 2017 SForm 4 → | Feb 24, 9:10 am EST | Scott B CappsVP, Clinical Research | 11,083 | $16.40 | $181,776 | 117,394 | −8.63% | plan? |
| Feb 22, 2017 MForm 4 → | Feb 24, 9:10 am EST | Scott B CappsVP, Clinical Research | 16,667 | $7.01 | $116,836 | 128,477 | — | plan? |
| Feb 21, 2017 AForm 4 → | Feb 22, 7:03 pm EST | James M McDermidSVP, CHRO | 6,280 | — | — | 9,676 | — | plan? |
| Feb 19, 2017 AFForm 4 → | Feb 22, 7:00 pm EST | William Robert MatthewsSenior VP, Operations, Quality | 21,754 | $17.25 | $266,927 | 36,300 | — | plan? |
| Feb 19, 2017 AFForm 4 → | Feb 22, 6:58 pm EST | James P MackinPresident & CEO | 108,298 | $17.25 | $1,331,476 | 443,449 | — | plan? |
| Feb 19, 2017 AFForm 4 → | Feb 22, 6:55 pm EST | David Ashley LeeExecutive VP, COO & CFO | 32,159 | $17.25 | $397,578 | 297,403 | — | plan? |
| Feb 19, 2017 AFForm 4 → | Feb 22, 6:53 pm EST | Amy HortonVP, Chief Accounting Officer | 17,845 | $17.25 | $219,662 | 96,117 | — | plan? |
| Feb 19, 2017 AFForm 4 → | Feb 22, 6:50 pm EST | Jean F HollowayVP, General Counsel | 23,794 | $17.25 | $280,451 | 52,153 | — | plan? |
| Feb 19, 2017 AFForm 4 → | Feb 22, 6:39 pm EST | David C GaleVP, Research & Development | 16,771 | $17.25 | $224,129 | 80,887 | — | plan? |
| Feb 19, 2017 AFForm 4 → | Feb 22, 6:36 pm EST | John E DavisSenior VP, Global Sales | 22,696 | $17.25 | $266,927 | 37,586 | — | plan? |
| Feb 19, 2017 AFForm 4 → | Feb 22, 6:33 pm EST | Scott B CappsVP, Clinical Research | 17,447 | $17.25 | $224,302 | 111,810 | — | plan? |
| Jan 3, 2017 DForm 4 → | Jan 5, 4:58 pm EST | James BensonDirector | 2,000 | $19.10 | $38,200 | 60,086 | — | plan? |
| Dec 31, 2016 MForm 5 → | Jul 11, 2017, 8:56 am EDT | John E DavisSenior VP, Global Sales | 3,305 | $12.60 | $41,642 | 40,891 | — | plan? |
| Nov 23, 2016 DForm 4 → | Nov 28, 4:45 pm EST | C Elkins RonaldDirector | 2,000 | $20.00 | $40,000 | 97,586 | — | plan? |
| Nov 14, 2016 DForm 4 → | Nov 16, 4:48 pm EST | C Elkins RonaldDirector | 2,000 | $18.65 | $37,302 | 99,586 | — | plan? |
| Oct 31, 2016 DForm 4 → | Nov 1, 4:32 pm EDT | James BensonDirector | 2,000 | $16.75 | $33,501 | 62,086 | — | plan? |
| Sep 20, 2016 DForm 4 → | Sep 22, 5:00 pm EDT | C Elkins RonaldDirector | 1,000 | $18.00 | $18,000 | 101,586 | — | plan? |
| Sep 15, 2016 DForm 4 → | Sep 16, 4:31 pm EDT | Ronald D McCallDirector | 3,000 | $17.54 | $52,631 | 153,248 | — | plan? |
| Sep 13, 2016 AForm 4 → | Sep 15, 5:00 pm EDT | William Robert MatthewsSenior VP, Operations, Quality | 1,156 | $17.39 | $20,100 | 18,970 | — | plan? |
| Sep 12, 2016 DMForm 4 → | Sep 14, 5:30 pm EDT | Jean F HollowayVP, General Counsel | 6,000 | $13.33 | $80,001 | 34,351 | — | plan? |
| Sep 12, 2016 GForm 4 → | Sep 14, 5:27 pm EDT | Harvey MorganDirector | 4,000 | — | — | 36,300 | — | plan? |
| Sep 12, 2016 DMForm 4 → | Sep 14, 5:21 pm EDT | David C GaleVP, Research & Development | 6,000 | $12.25 | $73,489 | 71,190 | — | plan? |
| Sep 12, 2016 DForm 4 → | Sep 14, 5:19 pm EDT | C Elkins RonaldDirector | 1,000 | $17.25 | $17,249 | 102,586 | — | plan? |
| Sep 9, 2016 DMForm 4 → | Sep 13, 6:07 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 65,166 | $12.02 | $783,329 | 274,112 | — | plan? |
| Sep 9, 2016 DForm 4 → | Sep 13, 6:06 pm EDT | Amy HortonVP, Chief Accounting Officer | 5,750 | $17.49 | $87,467 | 86,548 | — | plan? |
| Sep 9, 2016 DForm 4 → | Sep 13, 6:04 pm EDT | James BensonDirector | 10,000 | $17.18 | $171,800 | 64,086 | — | plan? |
| Jul 26, 2016 FMForm 4 → | Jul 28, 4:34 pm EDT | Amy HortonVP, Chief Accounting Officer | 16,774 | $9.83 | $164,936 | 88,548 | — | plan? |
| Jul 26, 2016 SForm 4 → | Jul 28, 4:31 pm EDT | C Elkins RonaldDirector | 2,000 | $14.00 | $28,000 | 103,586 | −1.89% | plan? |
| Jul 22, 2016 GForm 4 → | Jul 26, 7:38 am EDT | Harvey MorganDirector | 10,600 | — | — | 38,300 | — | plan? |
| Jun 30, 2016 MForm 5 → | Jul 11, 2017, 8:58 am EDT | Jean F HollowayVP, General Counsel | 2,919 | $11.26 | $32,864 | 55,072 | — | plan? |
| Jun 1, 2016 SForm 4 → | Jun 3, 7:03 am EDT | Ronald D McCallDirector | 10,000 | $11.56 | $115,600 | 156,248 | −6.02% | plan? |
| May 23, 2016 AForm 4 → | May 25, 4:39 pm EDT | Jon W SalvesonDirector | 8,734 | — | — | 74,086 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 MForm 4 → | Jun 15, 11:28 am EDT | Andrew M GreenSVP, Regulatory and Quality | 44,001 | — | — | 0 | — | 10b5-1 |
| Mar 6, 2019 MForm 4 → | Mar 8, 6:10 pm EST | Amy HortonVP, Chief Accounting Officer | 6,666 | $6.12 | $40,796 | 0 | — | |
| Mar 5, 2019 AForm 4 → | Mar 8, 10:23 am EST | Thomas J BogenschuetzVP, EMEA & General Manager | 12,787 | — | — | 12,787 | — | late |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:56 pm EST | Scott B CappsVP, Clinical Research | 7,265 | — | — | 7,265 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:55 pm EST | John E DavisSenior VP, Global Sales | 12,787 | — | — | 12,787 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:53 pm EST | Jean F HollowayVP, General Counsel | 12,787 | — | — | 12,787 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:52 pm EST | Amy HortonVP, Chief Accounting Officer | 7,992 | — | — | 7,992 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:51 pm EST | David Ashley LeeExecutive VP, COO & CFO | 15,257 | — | — | 15,257 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:49 pm EST | James P MackinPresident & CEO | 61,842 | — | — | 61,842 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:48 pm EST | Dennis B MaierVice President, Operations | 7,265 | — | — | 7,265 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:45 pm EST | James M McDermidSVP, CHRO | 11,625 | — | — | 11,625 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:43 pm EST | Michael S SimpsonSVP, Regulatory Affairs and QA | 11,625 | — | — | 11,625 | — | |
| Sep 18, 2018 MForm 4 → | Sep 20, 5:02 pm EDT | John E DavisSenior VP, Global Sales | 3,333 | $9.64 | $32,130 | 0 | — | |
| Aug 30, 2018 MForm 4 → | Sep 4, 6:59 pm EDT | Scott B CappsVP, Clinical Research | 8,332 | $5.67 | $47,242 | 0 | — | |
| Aug 15, 2018 MForm 4 → | Aug 16, 5:24 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 16,666 | $5.67 | $94,496 | 0 | — | |
| Aug 13, 2018 MForm 4 → | Aug 15, 5:48 pm EDT | James P MackinPresident & CEO | 150,000 | $10.24 | $1,536,000 | 16,265 | — | |
| Aug 10, 2018 MForm 4 → | Aug 13, 4:34 pm EDT | Jean F HollowayVP, General Counsel | 1,500 | $10.28 | $15,420 | 0 | — | |
| Aug 7, 2018 MForm 4 → | Aug 9, 5:27 pm EDT | Jean F HollowayVP, General Counsel | 4,000 | $10.28 | $41,120 | 1,500 | — | |
| Aug 7, 2018 JForm 4 → | Aug 9, 5:26 pm EDT | James P MackinPresident & CEO | 331,300 | — | — | 75,615 | — | |
| Jul 26, 2018 MForm 4 → | Jul 30, 4:32 pm EDT | John E DavisSenior VP, Global Sales | 3,391 | $16.30 | $55,273 | 0 | — | |
| Jul 23, 2018 MForm 4 → | Jul 25, 4:44 pm EDT | Jean F HollowayVP, General Counsel | 1,500 | $10.28 | $15,420 | 5,500 | — | |
| Jul 1, 2018 AMForm 5 → | Feb 19, 2019, 7:48 am EST | Sherry M SauriniVP, Quality | 226 | $23.67 | $5,350 | 0 | — | |
| Jul 1, 2018 AMForm 5 → | Feb 19, 2019, 7:47 am EST | James M McDermidSVP, CHRO | 178 | $23.67 | $4,214 | 0 | — | |
| Jul 1, 2018 AMForm 5 → | Feb 19, 2019, 7:46 am EST | Jean F HollowayVP, General Counsel | 614 | $23.67 | $14,535 | 0 | — | |
| Jun 14, 2018 MForm 4 → | Jun 15, 5:19 pm EDT | John E DavisSenior VP, Global Sales | 4,372 | $10.24 | $44,769 | 8,745 | — | |
| Jun 1, 2018 MForm 4 → | Jun 5, 4:23 pm EDT | Amy HortonVP, Chief Accounting Officer | 5,000 | $5.67 | $28,350 | 0 | — | |
| Jun 1, 2018 MForm 4 → | Jun 5, 4:22 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $10.24 | $44,780 | 13,117 | — | |
| May 16, 2018 DForm 4 → | May 18, 4:32 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $27.00 | $118,071 | 17,490 | — | |
| May 8, 2018 MForm 4 → | May 10, 4:43 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $10.24 | $44,780 | 17,491 | — | |
| May 3, 2018 MForm 4 → | May 8, 4:24 pm EDT | John E DavisSenior VP, Global Sales | 3,334 | $9.64 | $32,140 | 3,333 | — | late |
| Apr 17, 2018 MForm 4 → | Apr 18, 4:42 pm EDT | John E DavisSenior VP, Global Sales | 3,333 | $9.64 | $32,130 | 6,667 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:52 pm EDT | James M McDermidSVP, CHRO | 15,910 | — | — | 15,910 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:51 pm EDT | James P MackinPresident & CEO | 77,562 | — | — | 77,562 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:50 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 21,877 | — | — | 21,877 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:50 pm EDT | Amy HortonVP, Chief Accounting Officer | 12,430 | — | — | 12,430 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:49 pm EDT | Jean F HollowayVP, General Counsel | 19,092 | — | — | 19,092 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:48 pm EDT | John E DavisSenior VP, Global Sales | 15,910 | — | — | 15,910 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:47 pm EDT | Scott B CappsVP, Clinical Research | 9,944 | — | — | 9,944 | — | |
| Feb 13, 2018 MForm 4 → | Feb 15, 5:28 pm EST | Scott B CappsVP, Clinical Research | 31,333 | $17.10 | $535,794 | 0 | — | |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:49 pm EDT | Sherry M SauriniVP, Quality | 382 | $16.24 | $6,202 | 0 | — | late |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:47 pm EDT | James M McDermidSVP, CHRO | 2,358 | $16.24 | $38,282 | 0 | — | late |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:46 pm EDT | Jean F HollowayVP, General Counsel | 1,722 | $16.24 | $27,957 | 0 | — | late |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:43 pm EDT | John E DavisSenior VP, Global Sales | 6,007 | $16.27 | $97,744 | 16,953 | — | late |
| Dec 31, 2017 AMForm 5 → | Jan 25, 2018, 4:47 pm EST | James M McDermidSVP, CHRO | 1,642 | $16.28 | $26,728 | 0 | — | |
| Dec 31, 2017 AMForm 5 → | Jan 25, 2018, 4:46 pm EST | Jean F HollowayVP, General Counsel | 1,134 | $16.28 | $18,459 | 0 | — | |
| Nov 16, 2017 MForm 4 → | Nov 17, 4:17 pm EST | David C GaleVP, Research & Development | 20,000 | — | — | 0 | — | |
| Nov 8, 2017 MForm 4 → | Nov 13, 4:47 pm EST | David Ashley LeeExecutive VP, COO & CFO | 63,333 | $18.80 | $1,190,438 | 0 | — | late |
| Jun 27, 2017 MForm 4 → | Jun 29, 9:19 am EDT | Amy HortonVP, Chief Accounting Officer | 18,667 | — | — | 0 | — | |
| Feb 22, 2017 MForm 4 → | Feb 24, 9:10 am EST | Scott B CappsVP, Clinical Research | 16,667 | $16.40 | $273,360 | 0 | — | |
| Dec 31, 2016 AMForm 5 → | Jul 11, 2017, 8:56 am EDT | John E DavisSenior VP, Global Sales | 6,610 | — | — | 0 | — | |
| Sep 12, 2016 MForm 4 → | Sep 14, 5:30 pm EDT | Jean F HollowayVP, General Counsel | 3,000 | — | — | 3,000 | — | |
| Sep 12, 2016 MForm 4 → | Sep 14, 5:21 pm EDT | David C GaleVP, Research & Development | 3,000 | — | — | 3,000 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 6:07 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 33,333 | — | — | 1,500 | — | |
| Jul 26, 2016 MForm 4 → | Jul 28, 4:34 pm EDT | Amy HortonVP, Chief Accounting Officer | 10,000 | — | — | 0 | — | |
| Jun 30, 2016 AMForm 5 → | Jul 11, 2017, 8:58 am EDT | Jean F HollowayVP, General Counsel | 5,838 | — | — | 0 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:47 pm EST | Sherry M SauriniVP, Quality | 14,913 | — | — | 14,913 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:45 pm EST | William Robert MatthewsSenior VP, Operations, Quality | 26,236 | — | — | 26,236 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:44 pm EST | James P MackinPresident & CEO | 119,672 | — | — | 119,672 | — | amended |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:43 pm EST | David Ashley LeeExecutive VP, COO & CFO | 36,822 | — | — | 36,822 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:41 pm EST | Amy HortonVP, Chief Accounting Officer | 20,713 | — | — | 20,713 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:39 pm EST | Jean F HollowayVP, General Counsel | 26,236 | — | — | 26,236 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:37 pm EST | David C GaleVP, Research & Development | 20,713 | — | — | 20,713 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:36 pm EST | John E DavisSenior VP, Global Sales | 26,236 | — | — | 26,236 | — | |
| Feb 19, 2016 AMForm 4 → | Feb 23, 5:35 pm EST | Scott B CappsVP, Clinical Research | 35,713 | — | — | 418 | — | |
| Feb 17, 2016 MForm 4 → | Feb 19, 4:36 pm EST | Amy HortonVP, Chief Accounting Officer | 9,000 | — | — | 9,000 | — | |
| Feb 17, 2016 MForm 4 → | Feb 19, 4:35 pm EST | David Ashley LeeExecutive VP, COO & CFO | 20,700 | — | — | 8,000 | — | |
| Dec 28, 2015 MForm 4 → | Dec 30, 3:25 pm EST | David Ashley LeeExec. VP, COO and CFO | 1,000 | — | — | 8,200 | — | |
| Nov 27, 2015 MForm 4 → | Dec 1, 4:35 pm EST | David Ashley LeeExecutive VP, COO & CFO | 15,800 | — | — | 8,500 | — | |
| Sep 10, 2015 AForm 4/A → | Sep 17, 8:36 am EDT | Jean F HollowayVP, General Counsel | 20,307 | — | — | 20,307 | — | |
| Sep 10, 2015 AForm 4/A → | Sep 17, 8:34 am EDT | William Robert MatthewsSenior VP, Operations, Quality | 8,000 | — | — | 8,000 | — | |
| Sep 10, 2015 AForm 4 → | Sep 17, 8:30 am EDT | John E DavisSenior VP, Global Sales | 10,000 | — | — | 10,000 | — | late |
| Sep 10, 2015 AForm 4 → | Sep 15, 7:02 am EDT | William Robert MatthewsSenior VP, Operations, Quality | 8,000 | — | — | 8,000 | — | late amended |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:50 pm EDT | Jean F HollowayVP, General Counsel | 20,307 | — | — | 20,307 | — | amended |
| Apr 1, 2015 AForm 4 → | Apr 2, 5:00 pm EDT | Jean F HollowayVP, General Counsel | 7,000 | — | — | 7,000 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 8:36 am EST | Steven G AndersonExecutive Chairman | 63,750 | — | — | 0 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:55 pm EST | James P MackinPresident & CEO | 85,105 | — | — | 85,105 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:53 pm EST | David Ashley LeeExecutive VP, COO & CFO | 34,042 | — | — | 34,042 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:52 pm EST | David P. LangVP, Int'l Sales & Marketing | 20,425 | — | — | 20,425 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:50 pm EST | Amy HortonChief Accounting Officer | 13,617 | — | — | 13,617 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:49 pm EST | David C GaleVP, Research & Development | 20,425 | — | — | 20,425 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:47 pm EST | David FronkVP, Regulatory Affairs | 23,829 | — | — | 23,829 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:46 pm EST | Scott B CappsVP, Clinical Research | 20,425 | — | — | 20,425 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:43 pm EST | Bruce G. AndersonVP, US Sales &Global Marketing | 20,425 | — | — | 20,425 | — | |
| Feb 16, 2015 MForm 4 → | Feb 25, 8:33 am EST | David FronkVP, Regulatory Affairs | 15,000 | — | — | 0 | — | late |